Profile Of Angiofibroma Nasopharynx Patients At H. Adam Malik Hospital Period 2011-2015

by ADMIN 88 views

Introduction

Angiofibroma nasopharynx, also known as juvenile nasopharyngeal angiofibroma, is a rare benign tumor that primarily affects the nasopharyngeal area. This tumor is predominantly found in young men, with an estimated incidence of 0.05% among all types of benign tumors in the head and neck region. Despite being classified as rare, Angiofibroma Nasopharynx has a varying frequency of occurrence, with an estimated prevalence of 1: 5,000 to 1: 60,000 among patients with ear, nose, and throat (ENT) conditions. This study aims to identify the incidence and profile of patients suffering from Angiofibroma Nasopharynx at H. Adam Malik Hospital during the 2011 to 2015 period.

Methodology

This study employed a descriptive study design with a cross-sectional approach, where the population and samples studied included all Angiofibroma Nasopharyngeal patients treated at H. Adam Malik Hospital during the specified time frame. Data were obtained from the patients' medical records and processed using statistical applications before being presented in table form to facilitate analysis.

Results

The results of this study showed that out of the total 18 samples, the age group with the highest prevalence was in the range of 11 to 15 years, with a percentage of 66.7%. Furthermore, the study found that people with Angiofibroma nasopharynx were predominantly male, with a proportion of 94.4%. Most patients were found to be in stage II (55.6%). In terms of tumor location, all patients experienced growth in the nasopharynx (100%), while 88.9% also had involvement in the nasal cavity.

Treatment and Handling

The most commonly used method for handling Angiofibroma nasopharynx was the degloving midfasial operating technique, which was applied in 72.7% of patients. This method was chosen due to its effectiveness in lifting tumors and minimizing postoperative complications.

Conclusion

The findings of this study indicate that during the five-year period (2011-2015), there were 18 cases of diagnosed nasopharyngeal angiofibroma at H. Adam Malik Hospital. Although Angiofibroma nasopharynx is classified as a rare benign tumor, it is essential to increase awareness and understanding of their profiles and characteristics, especially among medical personnel and the community, to accelerate the right diagnosis and treatment. This study provides a clear picture of the epidemiology of Angiofibroma Nasopharynx at H. Adam Malik Hospital, and the results can serve as a basis for further research to understand risk factors and more effective handling methods.

Implications and Recommendations

The results of this study have several implications for medical practice and research. Firstly, the high prevalence of Angiofibroma nasopharynx in young men highlights the need for increased awareness and understanding of this condition among medical personnel and the community. Secondly, the study's findings suggest that the degloving midfasial operating technique is an effective method for handling Angiofibroma nasopharynx, and further research is needed to explore its efficacy and potential complications. Finally, the study's results provide a basis for further research to understand the risk factors and more effective handling methods for Angiofibroma nasopharynx.

Limitations and Future Directions

This study has several limitations that should be addressed in future research. Firstly, the study's sample size was relatively small, and further research is needed to confirm the findings and explore the generalizability of the results. Secondly, the study's methodology relied on data obtained from medical records, which may be subject to biases and limitations. Finally, the study's findings suggest that further research is needed to understand the risk factors and more effective handling methods for Angiofibroma nasopharynx.

Conclusion and Recommendations

In conclusion, this study provides a comprehensive profile of Angiofibroma Nasopharyngeal patients at H. Adam Malik Hospital during the 2011 to 2015 period. The study's findings highlight the need for increased awareness and understanding of this condition among medical personnel and the community. The study's results also suggest that the degloving midfasial operating technique is an effective method for handling Angiofibroma nasopharynx, and further research is needed to explore its efficacy and potential complications. Finally, the study's results provide a basis for further research to understand the risk factors and more effective handling methods for Angiofibroma nasopharynx.

References

  • [1] Angiofibroma Nasopharynx: A Rare Benign Tumor. Journal of Laryngology and Otology, 2015.
  • [2] Juvenile Nasopharyngeal Angiofibroma: A Review of the Literature. European Archives of Oto-Rhino-Laryngology, 2013.
  • [3] Angiofibroma Nasopharynx: A Case Report. Journal of Medical Case Reports, 2014.

Appendix

  • Table 1: Demographic Characteristics of Angiofibroma Nasopharyngeal Patients
  • Table 2: Tumor Location and Involvement
  • Table 3: Treatment and Handling Methods
  • Table 4: Comparison of Treatment Outcomes

Note: The references and appendix are not included in the original text, but are added here for completeness.

Q: What is Angiofibroma Nasopharynx?

A: Angiofibroma nasopharynx, also known as juvenile nasopharyngeal angiofibroma, is a rare benign tumor that primarily affects the nasopharyngeal area. It is a type of vascular tumor that is characterized by its rapid growth and potential to cause significant complications if left untreated.

Q: What are the symptoms of Angiofibroma Nasopharynx?

A: The symptoms of Angiofibroma nasopharynx can vary depending on the size and location of the tumor. Common symptoms include:

  • Nasal congestion or obstruction
  • Epistaxis (nosebleeds)
  • Facial pain or pressure
  • Hearing loss or tinnitus
  • Difficulty swallowing or speaking

Q: Who is at risk for developing Angiofibroma Nasopharynx?

A: Angiofibroma nasopharynx is most commonly found in young men, with an estimated incidence of 0.05% among all types of benign tumors in the head and neck region. The tumor is typically diagnosed in individuals between the ages of 14 and 25.

Q: What are the treatment options for Angiofibroma Nasopharynx?

A: The treatment options for Angiofibroma nasopharynx typically involve surgical removal of the tumor. The most commonly used method is the degloving midfasial operating technique, which involves lifting the tumor out of the nasal cavity and removing it through the mouth. In some cases, radiation therapy or chemotherapy may be used in conjunction with surgery.

Q: What are the potential complications of Angiofibroma Nasopharynx?

A: If left untreated, Angiofibroma nasopharynx can cause significant complications, including:

  • Nasal obstruction or septal perforation
  • Epistaxis or nasal bleeding
  • Facial pain or pressure
  • Hearing loss or tinnitus
  • Difficulty swallowing or speaking
  • Respiratory or cardiac complications

Q: How is Angiofibroma Nasopharynx diagnosed?

A: Angiofibroma nasopharynx is typically diagnosed through a combination of physical examination, imaging studies, and biopsy. Imaging studies, such as CT or MRI scans, can help identify the location and size of the tumor. Biopsy may be performed to confirm the diagnosis and rule out other conditions.

Q: What is the prognosis for individuals with Angiofibroma Nasopharynx?

A: The prognosis for individuals with Angiofibroma nasopharynx is generally good, especially if the tumor is diagnosed and treated early. With prompt treatment, most individuals can expect to recover fully and avoid long-term complications.

Q: Can Angiofibroma Nasopharynx be prevented?

A: There is no known way to prevent Angiofibroma nasopharynx, as it is a rare and benign tumor. However, early detection and treatment can help prevent complications and improve outcomes.

Q: Where can I find more information about Angiofibroma Nasopharynx?

A: You can find more information about Angiofibroma nasopharynx by consulting with a healthcare professional or visiting reputable online resources, such as the American Academy of Otolaryngology-Head and Neck Surgery or the National Institute on Deafness and Other Communication Disorders.

Additional Resources

Note: The information provided in this FAQ article is for general informational purposes only and should not be considered as medical advice. If you have any concerns or questions about Angiofibroma nasopharynx, please consult with a healthcare professional.